Event Welcome
Chairs: Marianna Fontana & Perry Elliott, London, UK
Session 1: The Cardiomyopathy Mindset
Chairs: Marianna Fontana & Perry Elliot, London, UK
Faculty: Elena Arbelo, Barcelona, SP; Caroline Coats, Glasgow, UK; Sanjay Sharma, London, UK
Presentations
-
Case Study Presentation
-
When Do You Suspect Cardiomyopathy?
-
Overview of the Diagnostic Pathway
Session 2: The Diagnostic Pathway
Chairs: Marianna Fontana & Perry Elliott, London, UK
Faculty: Ahmad Masri, Portland, US; Caroline Coats, Glasgow, UK; Victoria Delgado, Barcelona, ES
Presentations
-
Assessing Ventricular Function in Cardiomyopathy Diagnosis
-
Beyond Imaging: Diagnostic Tools for Cardiomyopathy
-
Precision Diagnosis: The Role of Phenotyping in Cardiomyopathy
Session 3: The Management of Cardiomyopathy
Chairs: Perry Elliott, London, UK; Rodney Falk, Boston, US
Faculty: Elena Arbelo, Barcelona, SP; Jacob Tfelt-Hansen, Copenhagen, DK; Ahmad Masri, Portland, US.
Presentations
-
Risk Stratification & Prognostic Assessment
-
The General Approach to Management
-
Management of Our Case Study: Hypertrophic Cardiomyopathy Patient
Event Welcome
Chairs: Marianna Fontana, London, UK & Rodney Falk, Boston, US
Session 1: Amyloidosis Specific Diagnosis
Chairs: Marianna Fontana, London, UK & Rodney Falk, Boston, US
Faculty: Arnt Kristen, Heidelberg, DE; Margot Davis, Vancouver, CA; Sarah Cuddy, Boston, US
Presentations:
-
Presentation of Case Study: Clues for Amyloidosis
-
Amyloidosis Specific Investigations
-
Scintigraphy Challenge: Addressing Possible MGUS with Suggestive ATTR
-
CMR 101 for Cardiac Amyloidosis
Session 2: Implementation in Practice
Chairs: Marianna Fontana, London, UK & Rodney Falk, Boston, US
Faculty: João Agostinho, Lisbon, PT; Ahmad Masri, Portland, US
Presentations
-
Coordinating Diagnostic Testing with Referral: a Real-World Example
-
Complex case: A Complex Diagnostic and Management Problem
Session 3: Phenotyping Management Strategies
Chairs: Marianna Fontana, London, UK & Rodney Falk, Boston, US
Faculty: João Agostinho, Lisbon, PT; Sarah Cuddy, Boston, US, Ahmad Masri, Portland, US
Presentations
Working with the Haematologist: Cardiac Complexities and Complications During Chemotherapy
Advanced Treatment Strategies for AL Amyloidosis: Device Therapy and Transplant Options
Treatment Options for Advanced Cardiomyopathy and Frail Patients: Do They Differ?
Unravelling the Pathways to Early Intervention in ATTR-CM
Chair: Julian Gillmore, London, UK
Faculty: Margot Davis, Vancouver, CA; Ahmad Masri, Portland, US
Welcome and Introduction – Julian Gillmore, London, UK
Case Study – Ahmad Masri, Portland, US
Managing Disease Early – Julian Gillmore, London, UK
ATTR Stabilisation: Current Standard of Care – Margot Davis, Vancouver, CA
What Are Our Future Options? Panel Discussion and Q&A – All
This symposium is supported by an unrestricted educational grant from Bayer.
*Unravelling the Pathways to Early Intervention in ATTR-CM has been accredited by the European Board for Accreditation of Continuing Education for Health Professionals (EBAC) for 1 CME point, equating to 1 hour of learning. Physicians may convert EBAC External CME credits to AMA PRA Category 1 Credits™.
Session 4: The Treatment Horizon
Chairs: Rodney Falk, Boston, US
Faculty: Arnt Kristen, Heidelberg, DE; Margot Davis, Vancouver, CA; Julian Gillmore, London, UK
Presentations
Key Overview of Recently Completed and On-Going Trials: Translations to Clinical Practice
The Reversal Debate